Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1996-05-08
1998-09-22
Scheiner, Toni R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241331, 4241411, 4241431, 4241521, 4241541, 4241301, 4241351, 424810, 514 2, 514 12, 514885, 5303871, 5303873, 5303881, 53038822, 5303887, C07K 1628, C07K 14725, A61K 39395
Patent
active
058110976
ABSTRACT:
T cell activation in response to antigen is increased by the administration of binding agents that block CTLA-4 signaling. When CTLA-4 signaling is thus blocked, the T cell response to antigen is released from inhibition. Such an enhanced response is useful for the treatment of tumors, chronic viral infections, and as an adjuvant during immunization.
REFERENCES:
patent: 556763 (1896-09-01), Ochoa et al.
patent: 5434131 (1995-07-01), Linsley et al.
Damle et al., "Costimulation of T Lymphocytes with Integrin Ligands Intercellular Adhesion Molecule-1 or Vascular Cell Adhesion Molecule-1 Induces Functional Expression of CTLA-4, A Second Receptor for B7," Journal of Immunology 152:2686-2697 (1994).
Lin et al., "Long-Term Acceptance of Major Histocompatibility Complex Mismatched Cardiac Allografts Induced by CTLA4lg Plus Donor-Specific Transfusion," J. Exp. Med. 178:1801-1806 (1993).
Turka et al., "T-Cell Activation by the CD28 Ligand B7 is Required for Cardiac Allograft Rejection in vivo," Proc. Natl. Acad. Sci. USA 89:11102-11105 (1992).
Linsley, P.S. and J.A. Ledbetter, "The Role of the CD28 Receptor During T Cell Responses to Antigen," Ann. Rev. Immunol. 11:191-212 (1993).
Wu et al., "CTLA-4-B7 Interaction is Sufficient to Costimulate T Cell Clonal Expansion," J. Exp. Med. 185(7):1327-1335 (1997).
Linsley, P.S., "Distinct Roles for CD28 and Cytotoxic Lymphocyte-Associated Molecule-4 Receptors During T Cell Activation," J. Exp. Med., 182:289-292 (1995).
Walumas, TL et al Immunity 1:403-413, Aug. 1994.
Kearney ER et al J. Immunol 155:1032-1036 Aug. 1, 1995.
Allison James Patrick
Krummel Matthew F.
Leach Dana R.
Lucas John
Scheiner Toni R.
The Regents of the University of California
LandOfFree
Blockade of T lymphocyte down-regulation associated with CTLA-4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blockade of T lymphocyte down-regulation associated with CTLA-4 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blockade of T lymphocyte down-regulation associated with CTLA-4 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1620108